Nouhad Husseini

Director/Board Member at DECIBEL THERAPEUTICS, INC.

Health Technology

Consumer Services

Profile

Nouhad Husseini is currently the Director & Managing Director at Checkmate Pharmaceuticals, Inc. and Decibel Therapeutics, Inc. He also holds the position of Senior VP-Business Development at Regeneron Pharmaceuticals, Inc. Husseini completed his undergraduate degree at Princeton University and obtained an MBA from The Wharton School of the University of Pennsylvania.

Latest news about Nouhad Husseini

Decibel Therapeutics, Inc. Announces Board Changes	23-09-25	CI
Checkmate Pharmaceuticals : Completion of Acquisition or Disposition of Assets - Form 8-K	22-05-31	PU
CHECKMATE PHARMACEUTICALS, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22-05-31	AQ
Checkmate Pharmaceuticals, Inc. Announces Board Changes	22-05-31	CI
Checkmate Pharmaceuticals : TENDER AND SUPPORT AGREEMENT - Form 8-K	22-04-19	PU

Nouhad Husseini active positions

Companies	Position	Start
REGENERON PHARMACEUTICALS, INC.	Corporate Officer/Principal	2010-12-31
CHECKMATE PHARMACEUTICALS, INC.	Director/Board Member	2022-05-30
DECIBEL THERAPEUTICS, INC.	Director/Board Member	2023-09-21

All active positions of Nouhad Husseini

Training of Nouhad Husseini

Princeton University	Undergraduate Degree
The Wharton School of the University of Pennsylvania	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nouhad Husseini's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
REGENERON PHARMACEUTICALS, INC.	Health Technology

Private companies	2
Checkmate Pharmaceuticals, Inc. Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA.	Health Technology
Decibel Therapeutics, Inc. Decibel Therapeutics, Inc. BiotechnologyHealth Technology Decibel Therapeutics, Inc. discovers and develops medicines to protect, repair, and restore hearing. The firm focuses on hearing disorders, including noise-induced hearing loss, residual hearing preservation or improved sound fidelity with cochlear implants, presbycusis or age-related hearing loss, tinnitus, a persistent ringing in the ears, and genetic hearing loss. It also offers drugs for pediatric cancer and cystic fibrosis patients who experience ototoxicity or hearing loss. The company was founded in October 2015 and is headquartered in Boston, MA.	Health Technology